Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
OKE ONEOK Inc
MMS Maximus Inc
HIIIU Hudson Executive Investment Corp III
UHAL Amerco
BAC Bank of America Corp
BA Boeing Co
EGRNF China Evergrande Group
SHYF Shyft Group Inc
NGS Natural Gas Services Group Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company commercializes medicines and product candidates for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, Kevzara (sarilumab) Solution for Subcutaneous Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion.

Closing Price
$651.88
Day's Change
-1.30 (-0.20%)
Bid
--
Ask
--
B/A Size
--
Day's High
653.00
Day's Low
643.29
Volume
(Average)
Volume:
762,045

10-day average volume:
710,577
762,045
  • Prev Close
    653.18
  • Today's Open
    649.17
  • Day's Range
    643.29-653.00
  • Avg Vol (10-day)
    710.6K
  • Last (time)
    4:00p ET 09/17/21
  • Last (size)
    1
  • 52-Wk Range
    441.00 - 686.62
    LowHigh
  • (03/04/21 - 09/03/21)
    5.06%
  • 26.6%
  • Market Cap
    69.7B
  • Shares Outstanding
    107.0M
  • 55.71
  • 11.73x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.2
  • 87.44
  • (% of float 08/31/21)
    1.33

Latest News

September 17, 2021
5:18 pm ET
MarketWatch
6:21 am ET
MarketWatch
September 16, 2021
5:19 pm ET
MarketWatch
September 15, 2021
5:19 pm ET
MarketWatch
7:40 am ET
MarketWatch
September 14, 2021
5:34 pm ET
PR Newswire
5:19 pm ET
MarketWatch
8:38 am ET
MarketWatch
September 13, 2021
5:19 pm ET
MarketWatch
September 10, 2021
5:19 pm ET
MarketWatch
September 09, 2021
5:19 pm ET
MarketWatch
11:39 am ET
MarketWatch
September 08, 2021
4:05 pm ET
PR Newswire
August 23, 2021
6:30 am ET
MarketWatch
August 21, 2021
3:16 pm ET
MarketWatch
August 20, 2021
6:48 am ET
MarketWatch
August 19, 2021
10:32 am ET
BusinessWire
August 05, 2021
6:55 am ET
MarketWatch
6:44 am ET
MarketWatch
6:44 am ET
MarketWatch
6:41 am ET
MarketWatch
6:41 am ET
MarketWatch
6:40 am ET
MarketWatch
6:40 am ET
MarketWatch
August 04, 2021
5:05 pm ET
PR Newswire
August 03, 2021
7:01 am ET
PR Newswire
July 27, 2021
7:53 am ET
MarketWatch
7:00 am ET
PR Newswire
July 20, 2021
6:39 am ET
MarketWatch
1:00 am ET
PR Newswire
July 08, 2021
6:24 am ET
MarketWatch
July 07, 2021
4:15 pm ET
PR Newswire
7:48 am ET
MarketWatch
June 28, 2021
9:31 am ET
PR Newswire
12:59 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.